<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item key="owner">ArrayExpress Uploader</item><item key="pop_total">0</item><item key="species">human</item><item key="factors"><item><item key="GSM538607"><item key="TRANSFECTANT">transfected with plasmid containing control GFP</item></item></item><item><item key="GSM538608"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PRWT )</item></item></item><item><item key="GSM538609"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PR2VR )</item></item></item><item><item key="GSM538607"><item key="TRANSFECTANT">transfected with plasmid containing control GFP</item></item></item><item><item key="GSM538608"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PRWT )</item></item></item><item><item key="GSM538609"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PR2VR )</item></item></item><item><item key="GSM538607"><item key="TRANSFECTANT">transfected with plasmid containing control GFP</item></item></item><item><item key="GSM538608"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PRWT )</item></item></item><item><item key="GSM538609"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PR2VR )</item></item></item><item><item key="GSM538607"><item key="TRANSFECTANT">transfected with plasmid containing control GFP</item></item></item><item><item key="GSM538608"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PRWT )</item></item></item><item><item key="GSM538609"><item key="TRANSFECTANT">transfected with plasmid containing wild type PML-RAR&#945; cDNA (pEGFP-PR2VR )</item></item></item></item><item key="id">3644</item><item key="ownerprofile_id">arrayexpress_sid</item><item key="platform">4</item><item key="summary_wrapped">Previous studies in our laboratory demonstrated that the azurophil granule protease neutrophil elastase (NE) cleaves PML-RARA (PR), the...</item><item key="geo_gse_id">E-GEOD-21550</item><item key="owner_profile">/profile/8773/arrayexpressuploader</item><item key="factor_count">1</item><item key="sample_count">12</item><item key="tags"><item>azurophil granule</item><item>disease</item><item>leukemia</item><item>median</item><item>neutrophil</item><item>protein</item></item><item key="lastmodified">Dec.12, 2014</item><item key="is_default">False</item><item key="geo_gds_id"/><item key="slug">effect-of-protease-resistant-pml-rar-on-the-leukem</item><item key="geo_id_plat">E-GEOD-21550_A-AFFY-44</item><item key="name">Effect of Protease-resistant PML-RAR&#945; on the leukemogenic potential in a mouse model of Acute Promyelocytic Leukemia</item><item key="created">Sep.15, 2014</item><item key="summary">Previous studies in our laboratory demonstrated that the azurophil granule protease neutrophil elastase (NE) cleaves PML-RARA (PR), the fusion protein that initiates acute promyelocytic leukemia (APL). Further, NE deficiency reduces the penetrance of APL in a murine model of this disease. We therefore predicted that NE-mediated PR cleavage might be important for its ability to initiate APL. To test this hypothesis, we generated a mouse expressing NE-resistant PR. These mice developed APL indistinguishable from wild type PR, but with significantly reduced latency (median leukemia-free survival of 274 days versus 473 days for wild type PR, p&lt;0.001).  Resistance to proteolysis may increase the abundance of full length PR protein in early myeloid cells, and our previous data suggested that non-cleaved PR may be less toxic to early myeloid cells. Together, these effects appear to increase the leukemogenicity of NE-resistant PR, contrary to our previous prediction. We conclude that NE deficiency may reduce APL penetrance via indirect mechanisms that are still NE dependent.  Keywords: Time course U937 cells were transfected with one of three tagged constructs GFP,GFP-PR,GFP-PR-2VR sorted for GFP positivity at the indicated time points and harvested for RNA.</item><item key="source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21550</item><item key="sample_source">http://www.ebi.ac.uk/arrayexpress/experiments/E-GEOD-21550/samples/</item></data></biogps>
